Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers November 21, 2017
Pharmacy Choice - Pharmaceutical News - FDA Grants New Clearance for Brain Surgery Technology - November 21, 2017

Pharmacy News Article

 2/13/17 - FDA Grants New Clearance for Brain Surgery Technology

By a News Reporter-Staff News Editor at Pharma Business Week - The U.S. Food and Drug Administration (FDA) in less than a 15-month period has granted a new and updated 510(k) clearance for two patented technologies made by NICO Corporation that are used in a new approach for brain surgery. Most recently, NICO received a new clearance for specific neurosurgical indications on its patented HYPERLINK "" \nMyriad automated tissue removal technology. The new clearance provides specific disease state approval for primary and secondary brain tumors, vascular abnormalities and malformations, and intraventricular tumors and cysts (see also NICO Corporation).

NICO also received an updated clearance in July 2015 for its patented HYPERLINK "" \nBrainPath access technology, now cleared for use in specific disease states such as high grade gliomas and Glioblastoma Multiforme that has only a 15-month survival rate, secondary metastatic tumors, and vascular abnormalities like intracerebral hemorrhage - the deadliest form of stroke. Both the Myriad and BrainPath are used in the rapidly growing brain tumor and hemorrhagic stroke markets that include almost 500,000 combined incidences in the U.S. annually and 5.2 million worldwide.

The addition of these combined indications by the FDA are key milestones for the company, whose integrated technologies are used as a system in a new approach to brain surgery. The ability to combine these technologies to gain non-invasive access, perform automated tumor removal and clot evacuation near critical structures, while collecting and preserving removed tissue and clots are helping redefine the notion of "inoperable" brain surgery.

"NICO has spent the last five years bringing together key technology elements to enable minimally invasive neurosurgery for subcortical tumors and clots," said Jim Pearson, president and CEO of NICO Corporation. "The goal of NICO has always been to create technology that could create less deficits and faster recoveries in brain surgery. The clinical evidence shows this is possible, and we believe that is directly related to finding less disruptive ways to access the brain that were not possible before. And we believe it will revolutionize the intracranial neurosurgical market."

Myriad is an automated, multi-functional tool used for precise resection, suction, clot evacuation and tumor removal in neurosurgery, spinal surgery, ENT and otolaryngology. Nearly 12,000 procedures have been performed using the technology.

"The Myriad system more efficiently preserves the tumor viability allowing me to culture the cells and develop personalized therapies for my patients," said Lawrence Dickinson, MD, neurosurgeon at Pacific Brain and Spine in Castro Valley, Calif. "This was not possible with older ultrasonic aspirating technologies."

Dr. Dickinson added that BrainPath has "revolutionized" his approach to surgical treatment of glial tumors of the cerebrum. "The system allows me to remove these tumors through smaller exposures and with minimal manipulation of the normal brain anatomy," he said.

Minimally invasive technologies like Myriad and BrainPath are key drivers to more surgical procedures being performed, with documented benefits to patients resulting in fewer days in the hospital, improved recoveries and less cost. Pearson said there is an increasing demand for this same kind of approach involving brain surgery. But until now, the right tools and technologies were not available to offer surgeons an integrated, standardized approach that was better for the healthcare institution, better for the patient, and better economically, he added.

Learn more about the Myriad and BrainPath by visiting HYPERLINK "" \, follow news updates on HYPERLINK "" \nLinkedIn, and view videos showing surgery using BrainPath and Myriad on YouTube at HYPERLINK "" \nNICOneuroCorp.

Keywords for this news article include: Technology, Neurosurgery, NICO Corporation, Government Agencies Offices and Entities.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2017, NewsRx LLC

(c) 2017 NewsRx LLC

Pharmacy News Index
  Drug Delivery Systems
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry


Last Chance
Nov 21: Standards of Practice for Filling Controlled Substance Prescriptions in Florida
Last Chance
Nov 22: Medical Marijuana: Examining the Science, Not the Politics
Nov 27: Drug Diversion and the Law: Updates and Considerations
Nov 28: An Integrative Approach to Managing Arthritis
Nov 29: Influenza 2017-2018: An Update on Prevention and Treatment
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.

Websites »
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement